Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are commonly prescribed to the growing number of cancer patients (more than two million in the UK alone) often to treat hypertension. However, increased fatal cancer in ARB users in a randomized...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cardwell, Chris R, Mc Menamin, Úna C, Hicks, Blánaid M, Hughes, Carmel, Cantwell, Marie M, Murray, Liam J
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926686/
https://ncbi.nlm.nih.gov/pubmed/24521426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-12-28
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires